Top compounds associated with response to HIRA


Feature Type Standardized
Nominal ANOVA
mRNA rigosertib CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA barasertib CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA TAK-715 GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA tivantinib CTRPv2 pan-cancer AAC 0.18 0.0002
Download CSV